DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER

Palazzo, Claudio; Karim, Reatul; Evrard, Brigitte; Piel, Géraldine

doi:10.1016/B978-0-323-42866-8.00001-0

No full text

Contribution to collective works (Parts of books)

DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER

Palazzo, Claudio; Karim, Reatul; Evrard, Brigitte et al.

2016 • In Grumezescu, Alex (Ed.) Nanobiomaterials in drug delivery

Permalink
https://hdl.handle.net/2268/204145

DOI
10.1016/B978-0-323-42866-8.00001-0

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Nanoparticle; Blood-Brain Barrier; Liposome; Solid Lipid Nanocapsule; Polymeric Nanoparticles

Abstract :

[en] Blood-brain barrier (BBB) is a brain protective structure composed by endothelial cells, astrocytes and pericytes characterized by specific transport systems expressed on their surface. Moreover, the tight junctions, in the paracellular space, and the adherens junctions, in the basolateral space of the endothelial cells create a physical barrier hardly crossable from the most part of common drugs. Despite the BBB is vital for the central nervous system (CNS), it restricts drug delivery to this tissue. To overcome this obstacle many drug delivery systems (DDS) have been developed. Polymeric nanocarriers, solid lipid nanocarriers (SLN) and liposomes are developed to deliver drugs otherwise not able to pass the BBB, due to their physico-chemical characteristics. Besides their capacity to pass biological barriers, the potential advantages of nanocarriers are their capability to load a high quantity of drug with low cytotoxicity.

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Palazzo, Claudio ; Université de Liège > Département de pharmacie > Département de pharmacie

Karim, Reatul ; Université de Liège > Département de pharmacie > Pharmacie galénique

Evrard, Brigitte ; Université de Liège > Département de pharmacie > Pharmacie galénique

Piel, Géraldine ; Université de Liège > Département de pharmacie > Pharmacie galénique

Language :

English

Title :

DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER

Publication date :

2016

Main work title :

Nanobiomaterials in drug delivery

Publishing director :

Grumezescu, Alex

Publisher :

Elsevier

Available on ORBi :

since 08 December 2016

Statistics

Number of views

167 (7 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

See more details

publications

supporting

mentioning

contrasting

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Bibliography

Aderem, A., Underhill, D.M., Mechanisms of phagocytosis in macrophages (1999) Annu. Rev. Immunol., 17, pp. 593-623
Aggarwal, P., Hall, J.B., McLeland, C.B., Dobrovolskaia, M.A., McNeil, S.E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy (2009) Adv. Drug Deliv. Rev
Ahmad, S., Tester, R.F., Corbett, A., Karkalas, J., Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis (2006) Carbohydr. Res., 341, pp. 2694-2701
Alkilany, A.M., Murphy, C.J., Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? (2010) J. Nanopart. Res., 12, pp. 2313-2333
Allen, T.M., Martin, F.J., Advantages of liposomal delivery systems for anthracyclines (2004) Semin. Oncol
Angeli, E., Buzio, R., Firpo, G., Magrassi, R., Mussi, V., Repetto, L., Nanotechnology applications in medicine (2008) Tumori, pp. 206-215
Bae, K.H., Lee, K., Kim, C., Park, T.G., Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging (2011) Biomaterials, 32, pp. 176-184
Bao, G., Mitragotri, S., Tong, S., Multifunctional nanoparticles for drug delivery and molecular imaging (2013) Annu. Rev. Biomed. Eng., 15, pp. 253-282
Barenholz, Y., Liposome application: problems and prospects (2001) Curr. Opin. Colloid Interface Sci., , http://dx.doi.org/10.1016/S1359-0294(00)00090-X
Bates, P.J., Laber, D.A., Miller, D.M., Thomas, S.D., Trent, J.O., Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer (2009) Exp. Mol. Pathol
Bera, D., Qian, L., Tseng, T.K., Holloway, P.H., Quantum dots and their multimodal applications: a review (2010) Materials
Bertrand, N., Wu, J., Xu, X., Kamaly, N., Farokhzad, O.C., Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology (2014) Adv. Drug Deliv. Rev., 66, pp. 2-25
Bharali, D.J., Mousa, S.A., Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise (2010) Pharmacol. Ther., 128, pp. 324-335
Biju, V., Itoh, T., Ishikawa, M., Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging (2010) Chem. Soc. Rev., 39, pp. 3031-3056
Blanco, E., Kessinger, C.W., Sumer, B.D., Gao, J., Multifunctional micellar nanomedicine for cancer therapy (2009) Exp. Biol. Med. (Maywood), 234, pp. 123-131
Bozzaro, S., Cell surface carbohydrates and cell recognition in Dictyostelium (1985) Cell Differ., 17, pp. 67-82. , http://dx.doi.org/10.1016/0045-6039(85)90473-7
Brandley, B.K., Schnaar, R.L., Cell-surface carbohydrates in cell recognition and response (1986) J. Leukoc. Biol., 40, pp. 97-111
Brigger, I., Dubernet, C., Couvreur, P., Nanoparticles in cancer therapy and diagnosis (2002) Adv. Drug Deliv. Rev, , http://dx.doi.org/10.1016/S0169-409X(02)00044-3
Bucior, I., Burger, M.M., Carbohydrate-carbohydrate interactions in cell recognition (2004) Curr. Opin. Struct. Biol
Byrne, J.D., Betancourt, T., Brannon-Peppas, L., Active targeting schemes for nanoparticle systems in cancer therapeutics (2008) Adv. Drug Deliv. Rev., 60, pp. 1615-1626
Cai, W., Gao, T., Hong, H., Sun, J., Applications of gold nanoparticles in cancer nanotechnology (2008) Nanotechnol. Sci. Appl., pp. 17-32
Cheki, M., Moslehi, M., Assadi, M., Marvelous applications of quantum dots (2013) Eur. Rev. Med. Pharmacol. Sci., 17, pp. 1141-1148
Chen, G., Ohulchanskyy, T.Y., Kumar, R., Ågren, H., Prasad, P.N., Ultrasmall monodisperse NaYF4:Yb3+/Tm3+ nanocrystals with enhanced near-infrared to near-infrared upconversion photoluminescence (2010) ACS Nano, 4, pp. 3163-3168
Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S.S., Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release (2010) Bioconjug. Chem., 21, pp. 979-987
Chen, G., Yang, C., Prasad, P.N., Nanophotonics and nanochemistry: controlling the excitation dynamics for frequency up- and down-conversion in lanthanide-doped nanoparticles (2013) Acc. Chem. Res., 46, pp. 1474-1486
Chen, H., Ahn, R., Van den Bossche, J., Thompson, D.H., O'Halloran, T., Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide (2009) Mol. Cancer Ther., 8, pp. 1955-1963
Chithrani, B.D., Ghazani, A.A., Chan, W.C.W., Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells (2006) Nano Lett., 6, pp. 662-668
Choi, H.S., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Itty Ipe, B., Renal clearance of quantum dots (2002) Nat. Biotechnol., 25, pp. 1165-1170
Corti, C.W., Holliday, R.J., Thompson, D.T., Developing new industrial applications for gold: gold nanotechnology (2002) Gold Bull
Coulman, S.A., Anstey, A., Gateley, C., Morrissey, A., McLoughlin, P., Allender, C., Microneedle mediated delivery of nanoparticles into human skin (2009) Int. J. Pharm., 366, pp. 190-200
Couvreur, P., Nanoparticles in drug delivery: past, present and future (2013) Adv. Drug Deliv. Rev., 65, pp. 21-23
Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Préat, V., PLGA-based nanoparticles: an overview of biomedical applications (2012) J. Control. Release
Danhier, F., Breton, A., Le Préat, V., RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis (2012) Mol. Pharm., 9, pp. 2961-2973
Daniel, M.C., Astruc, D., Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology (2004) Chem. Rev
Das, M., Mishra, D., Dhak, P., Gupta, S., Maiti, T.K., Basak, A., Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging (2009) Small, 5, pp. 2883-2893
Dechantsreiter, M.A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., N-methylated cyclic RGD peptides as highly active and selective ?(v)?3 integrin antagonists (1999) J. Med. Chem., 42, pp. 3033-3040
Decuzzi, P., Lee, S., Bhushan, B., Ferrari, M.A., Theoretical model for the margination of particles within blood vessels (2005) Ann. Biomed. Eng., 33, pp. 179-190
De Jong, W.H., Borm, P.J., Drug delivery and nanoparticles: applications and hazards (2008) Int. J. Nanomed., 3, pp. 133-149
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel (2006) Clin. Cancer Res., 12, pp. 1317-1324
Doherty, G.J., McMahon, H.T., Mechanisms of endocytosis (2009) Annu. Rev. Biochem., 78, pp. 857-902
Dubey, I., Pratviel, G., Meunier, B., Modification of the thiourea linkage of a fluorescein-oligonucleotide conjugate to a guanidinium motif during ammonia deprotection (1998) Bioconjug. Chem., 9, pp. 627-632
Elbayoumi, T.A., Torchilin, V.P., Current trends in liposome research (2010) Methods Mol. Biol., 605, pp. 1-27
Forssen, E.A., Tokes, Z.A., Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes (1983) Cancer Res., 43, pp. 546-550
Gabizon, A., Shmeeda, H., Barenholz, Y., Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies (2003) Clin. Pharmacokinet., 42, pp. 419-436
Gao, W., Chan, J.M., Farokhzad, O.C., PH-responsive nanoparticles for drug delivery (2010) Mol. Pharm
Gao, X., Cui, Y., Levenson, R.M., Chung, L.W.K., Nie, S., In vivo cancer targeting and imaging with semiconductor quantum dots (2004) Nat. Biotechnol., 22, pp. 969-976
Gaspar, M.M., Radomska, A., Gobbo, O.L., Bakowsky, U., Radomski, M.W., Ehrhardt, C., Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats (2012) J. Aerosol. Med. Pulm. Drug Deliv
Gavasane, A.J., Synthetic biodegradable polymers used in controlled drug delivery system: an overview (2014) Clin. Pharmacol. Biopharm., 3
Gentile, P., Chiono, V., Carmagnola, I., Hatton, P.V., An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering (2014) Int. J. Mol. Sci
Gillies, E.R., Fréchet, J.M.J., PH-responsive copolymer assemblies for controlled release of doxorubicin (2005) Bioconjug. Chem., 16, pp. 361-368
Gillies, E.R., Jonsson, T.B., Fréchet, J.M.J., Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers (2004) J. Am. Chem. Soc., 126, pp. 11936-11943
Glaus, C., Rossin, R., Welch, M.J., Bao, G., In vivo evaluation of Cu-64-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent (2010) Bioconjug. Chem., 21, pp. 715-722
Gorelik, E., Galili, U., Raz, A., On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis (2001) Cancer Metastasis Rev
Gu, J., Cheng, W.P., Liu, J., Lo, S.Y., Smith, D., Qu, X., PH-triggered reversible "stealth" polycationic micelles (2008) Biomacromolecules, 9, pp. 255-262
Gu, Y., Zhong, Y., Meng, F., Cheng, R., Deng, C., Zhong, Z., Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy (2013) Biomacromolecules, 14, pp. 2772-2780
Guillén, D., Sánchez, S., Rodríguez-Sanoja, R., Carbohydrate-binding domains: multiplicity of biological roles (2010) Appl. Microbiol. Biotechnol
Gupta, A.K., Gupta, M., Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications (2005) Biomaterials
Hadjipanayis, C.G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A.J., Chen, H., EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma (2010) Cancer Res., 70, pp. 6303-6312
Hein, C.D., Liu, X.-M., Wang, D., Click chemistry, a powerful tool for pharmaceutical sciences (2008) Pharm. Res., 25, pp. 2216-2230
Heo, D.N., Yang, D.H., Moon, H.J., Lee, J.B., Bae, M.S., Lee, S.C., Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy (2012) Biomaterials, 33, pp. 856-866
Hilgenbrink, A.R., Low, P.S., Folate receptor-mediated drug targeting: from therapeutics to diagnostics (2005) J. Pharm. Sci
Huang, H.-C., Barua, S., Sharma, G., Dey, S.K., Rege, K., Inorganic nanoparticles for cancer imaging and therapy (2011) J. Control. Release, 155, pp. 344-357
Huang, Z., Sengar, R.S., Nigam, A., Abadjian, M.-C., Potter, D.M., Grotjahn, D.B., A fluorinated dendrimer-based nanotechnology platform: new contrast agents for high field imaging (2010) Invest. Radiol., 45, pp. 641-654
Hubbell, J.A., Synthetic biodegradable polymers for tissue engineering and drug delivery (1998) Curr. Opin. Solid State Mater. Sci, , http://dx.doi.org/10.1016/S1359-0286(98)80098-3
Hughes, J.D., Blagg, J., Price, D.A., Bailey, S., DeCrescenzo, G.A., Devraj, R.V., Physiochemical drug properties associated with in vivo toxicological outcomes (2008) Bioorg. Med. Chem. Lett., 18, pp. 4872-4875
Jain, R.K., Stylianopoulos, T., Delivering nanomedicine to solid tumors (2010) Nat. Rev. Clin. Oncol., 7, pp. 653-664
Jain, S., Hirst, D.G., O'Sullivan, J.M., Gold nanoparticles as novel agents for cancer therapy (2012) Br. J. Radiol., 85, pp. 101-113
Jinhao, G.A.O., Hongwei, G.U., Bing, X.U., Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications (2009) Acc. Chem. Res., 42, pp. 1097-1107
Jinno, J., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs (2006) J. Control. Release, 111, pp. 56-64
Johnston, H.J., Semmler-Behnke, M., Brown, D.M., Kreyling, W., Tran, L., Stone, V., Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro (2010) Toxicol. Appl. Pharmacol., 242, pp. 66-78
Jones, M.N., Carbohydrate-mediated liposomal targeting and drug delivery (1994) Adv. Drug Deliv. Rev, , http://dx.doi.org/10.1016/0169-409X(94)90013-2
Kale, A.A., Torchilin, V.P., Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the pH stability of PEG-PE conjugates (2007) Bioconjug. Chem., 18, pp. 363-370
Karmali, P.P., Kotamraju, V.R., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., Targeting of albumin-embedded paclitaxel nanoparticles to tumors (2009) Nanomedicine, 5, pp. 73-82
Keyes, J.D., Hilton, R.J., Farrer, J., Watt, R.K., Ferritin as a photocatalyst and scaffold for gold nanoparticle synthesis (2011) J. Nanopart. Res., 13, pp. 2563-2575
Kiessling, F., Liu, Z., Gätjens, J., Advanced nanomaterials in multimodal imaging: design, functionalization, and biomedical applications (2010) J. Nanomater., 2010
Kim, D., Chung, N.K., Allen, S., Tendler, S.J.B., Park, J.W., Ferritin-based new magnetic force microscopic probe detecting 10nm sized magnetic nanoparticles (2012) ACS Nano, 6, pp. 241-248
Kim, D.K., Zhang, Y., Voit, W., Rao, K.V., Muhammed, M., Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles (2001) J. Magn. Magn. Mater., 225, pp. 30-36. , http://dx.doi.org/10.1016/S0304-8853(00)01224-5
Kim, G.J., Nie, S., Targeted cancer nanotherapy (2005) Mater. Today, , http://dx.doi.org/10.1016/S1369-7021(05)71034-8
Kim, J., Park, S., Lee, J.E., Jin, S.M., Lee, J.H., Lee, I.S., Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy (2006) Angew. Chem. Int. Ed., 45, pp. 7754-7758
Kim, S.E., Ahn, K.Y., Park, J.S., Kim, K.R., Lee, K.E., Han, S.S., Fluorescent ferritin nanoparticles and application to the aptamer sensor (2011) Anal. Chem., 83, pp. 5834-5843
Kolb, H.C., Finn, M.G., Sharpless, K.B., Click chemistry: diverse chemical function from a few good reactions (2001) Angew. Chem. Int. Ed, , http://dx.doi.org/10.1002/1521-3773(20010601)40:112004:AID-ANIE20043.0.CO
2-5
Koolpe, M., Dail, M., Pasquale, E.B., An ephrin mimetic peptide that selectively targets the EphA2 receptor (2002) J. Biol. Chem., 277, pp. 46974-46979
Kuhn, D.A., Vanhecke, D., Michen, B., Blank, F., Gehr, P., Petri-Fink, A., Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages (2014) Beilstein J. Nanotechnol., 5, pp. 1625-1636
Laakkonen, P., Porkka, K., Hoffman, J.A., Ruoslahti, E., A tumor-homing peptide with a targeting specificity related to lymphatic vessels (2002) Nat. Med., 8, pp. 751-755
Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound (2005) Drug Dev. Ind. Pharm., 31, pp. 319-329
Lankveld, D.P., Rayavarapu, R.G., Krystek, P., Oomen, A.G., Verharen, H.W., van Leeuwen, T.G., Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats (2011) Nanomedicine (Lond.), 6, pp. 339-349
Larson, D.R., Zipfel, W.R., Williams, R.M., Clark, S.W., Bruchez, M.P., Wise, F.W., Water-soluble quantum dots for multiphoton fluorescence imaging in vivo (2003) Science, 300, pp. 1434-1436
Laurent, S., Mahmoudi, M., Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer (2011) Int. J. Mol. Epidemiol. Genet., 2, pp. 367-390
Laurent, S., Dutz, S., Häfeli, U.O., Mahmoudi, M., Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles (2011) Adv. Colloid Interface Sci
Leamon, C.P., Low, P.S., Folate-mediated targeting: from diagnostics to drug and gene delivery (2001) Drug Discov. Today, , http://dx.doi.org/10.1016/S1359-6446(00)01594-4
Lee, J.F., Stovall, G.M., Ellington, A.D., Aptamer therapeutics advance (2006) Curr. Opin. Chem. Biol
Lee, S.-Y., Cheng, J.-X., Clearance of nanoparticles during circulation (2013) Pharm. Sci. Encyclopedia, 9, pp. 1-32
Lepenies, B., Lee, J., Sonkaria, S., Targeting C-type lectin receptors with multivalent carbohydrate ligands (2013) Adv. Drug Deliv. Rev., 65, pp. 1271-1281
Li, J., Ji, J., Holmes, L.M., Burgin, K.E., Barton, L.B., Yu, X., Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor (2004) Cancer Gene Ther., 11, pp. 363-370
Li, Y., Lee, P.I., A new bioerodible system for sustained local drug delivery based on hydrolytically activated in situ macromolecular association (2010) Int. J. Pharm., 383, pp. 45-52
Li, Y., Dong, H., Wang, K., Shi, D., Zhang, X., Zhuo, R., Stimulus-responsive polymeric nanoparticles for biomedical applications (2010) Sci. China Chem., 53, pp. 447-457
Lian, T., Ho, R.J.Y., Trends and developments in liposome drug delivery systems (2001) J. Pharm. Sci
Lin, M.M., Kim, H.-H., Kim, H., Muhammed, M., Kim, D.K., Iron oxide-based nanomagnets in nanomedicine: fabrication and applications (2010) Nano Rev
Lin, P.C., Lin, S., Wang, P.C., Sridhar, R., Techniques for physicochemical characterization of nanomaterials (2014) Biotechnol. Adv
Longmire, M., Choyke, P.L., Kobayashi, H., Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats (2008) Nanomedicine (Lond.), 3, pp. 703-717
Low, P.S., Henne, W.A., Doorneweerd, D.D., Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases (2008) Acc. Chem. Res., 41, pp. 120-129
Love, S.A., Maurer-Jones, M.A., Thompson, J.W., Lin, Y.S., Haynes, C.L., Assessing nanoparticle toxicity (2012) Annu. Rev. Anal. Chem. (Palo Alto Calif.), 5, pp. 181-205
Lu, Y., Low, P.S., Folate-mediated delivery of macromolecular anticancer therapeutic agents (2012) Adv. Drug Deliv. Rev
Maeda, H., The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting (2001) Adv. Enzyme Regul., 41, pp. 189-207
Maeda, H., Nakamura, H., Fang, J., The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo (2013) Adv. Drug Deliv. Rev., 65, pp. 71-79
MaHam, A., Tang, Z., Wu, H., Wang, J., Lin, Y., Protein-based nanomedicine platforms for drug delivery (2009) Small
Maiti, S., Park, N., Han, J.H., Jeon, H.M., Lee, J.H., Bhuniya, S., Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug (2013) J. Am. Chem. Soc., 135, pp. 4567-4572
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L.A., Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform (2013) Nanomedicine
Mano, J.F., Stimuli-responsive polymeric systems for biomedical applications (2008) Adv. Eng. Mater
Massoud, T.F., Gambhir, S.S., Molecular imaging in living subjects: seeing fundamental biological processes in a new light (2003) Genes Dev., 17, pp. 545-580
Medeiros, S.F., Santos, A.M., Fessi, H., Elaissari, A., Stimuli-responsive magnetic particles for biomedical applications (2011) Int. J. Pharm., 403, pp. 139-161
Menjoge, A.R., Kannan, R.M., Tomalia, D.A., Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications (2010) Drug Discov. Today, 15, pp. 171-185
Merisko-Liversidge, E.M., Liversidge, G.G., Drug nanoparticles: formulating poorly water-soluble compounds (2008) Toxicol. Pathol., 36, pp. 43-48
Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., Quantum dots for live cells, in vivo imaging, and diagnostics (2005) Science, 307, pp. 538-544
Miele, E., Spinelli, G.P., Tomao, F., Tomao, S., Albumin-bound formulation of paclitaxel (Abraxane(registered trademark) ABI-007) in the treatment of breast cancer (2009) Int. J. Nanomed., 4, pp. 99-105
Minko, T., Drug targeting to the colon with lectins and neoglycoconjugates (2004) Adv. Drug Deliv. Rev., 56, pp. 491-509
Miranda, L.P., Shao, H., Williams, J., Chen, S.Y., Kong, T., Garcia, R., A chemical approach to the pharmaceutical optimization of an anti-HIV protein (2007) J. Am. Chem. Soc., 129, pp. 13153-13159
Mitra, S., Duggineni, S., Koolpe, M., Zhu, X., Huang, Z., Pasquale, E.B., Structure-activity relationship analysis of peptides targeting the EphA2 receptor (2010) Biochemistry, 49, pp. 6687-6695
Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice (2001) Pharmacol. Rev., 53, pp. 283-318
Moghimi, S.M., Hunter, A.C., Murray, J.C., Nanomedicine: current status and future prospects (2005) FASEB J., 19, pp. 311-330
Mongelard, F., Bouvet, P., AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia (2010) Curr. Opin. Mol. Ther., 12, pp. 107-114
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., Josephson, L., Multivalent effects of RGD peptides obtained by nanoparticle display (2006) J. Med. Chem., 49, pp. 6087-6093
Moore, A., Marecos, E., Bogdanov, A., Weissleder, R., Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model (2000) Radiology, 214, pp. 568-574
Mulder, W.J.M., Koole, R., Brandwijk, R.J., Storm, G., Chin, P.T.K., Strijkers, G.J., Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe (2006) Nano Lett., 6, pp. 1-6
Muthu, M., Nanoparticles based on PLGA and its co-polymer: an overview (2009) Asian J. Pharm
Nair, L.S., Laurencin, C.T., Polymers as biomaterials for tissue engineering and controlled drug delivery (2006) Adv. Biochem. Eng. Biotechnol
Nair, L.S., Laurencin, C.T., Biodegradable polymers as biomaterials (2007) Prog. Polym. Sci
Ng, E.W.M., Shima, D.T., Calias, P., Cunningham, E.T., Guyer, D.R., Adamis, A.P., Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease (2006) Nat. Rev. Drug Discov., 5, pp. 123-132
Nie, S., Understanding and overcoming major barriers in cancer nanomedicine (2010) Nanomedicine (Lond.), 5, pp. 523-528
Noyes, A.A., Whitney, W.R., The rate of solutions of solid substances in their own solutions (1897) J. Am. Chem. Soc., 19, pp. 930-934
Nyk, M., Kumar, R., Ohulchanskyy, T.Y., Bergey, E.J., Prasad, P.N., High contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors (2008) Nano Lett., 8, pp. 3834-3838
Oberdörster, G., Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology (2010) J. Intern. Med., pp. 89-105
Oberdörster, G., Oberdörster, E., Oberdörster, J., Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles (2005) Environ. Health Perspect
Oh, N., Park, J.H., Endocytosis and exocytosis of nanoparticles in mammalian cells (2014) Int. J. Nanomed., 9, pp. 51-63
Oishi, M., Nagatsugi, F., Sasaki, S., Nagasaki, Y., Kataoka, K., Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages (2005) ChemBioChem, 6, pp. 718-725
Pan, D., Caruthers, S.D., Hu, G., Senpan, A., Scott, M.J., Gaffney, P.J., Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets (2008) J. Am. Chem. Soc., 130, pp. 9186-9187
Panyam, J., Labhasetwar, V., Biodegradable nanoparticles for drug and gene delivery to cells and tissue (2003) Adv. Drug Deliv. Rev., 55, pp. 329-347
Park, H., Yang, J., Seo, S., Kim, K., Suh, J., Kim, D., Multifunctional nanoparticles for photothermally controlled drug delivery and magnetic resonance imaging enhancement (2008) Small, 4, pp. 192-196
Parton, R.G., Simons, K., The multiple faces of caveolae (2007) Nat. Rev. Mol. Cell Biol., 8, pp. 185-194
Pashov, A., Canziani, G., MacLeod, S., Plaxco, J., Monzavi-Karbassi, B., Kieber-Emmons, T., Targeting carbohydrate antigens in HIV vaccine development (2005) Vaccine, pp. 2168-2175
Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy (2007) Nat. Nanotechnol., 2, pp. 751-760
Podila, R., Brown, J.M., Toxicity of engineered nanomaterials: a physicochemical perspective (2013) J. Biochem. Mol. Toxicol
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic (2009) Crit. Rev. Ther. Drug Carrier Syst., 26, pp. 523-580
Qian, Z.M., Li, H., Sun, H., Ho, K., Targeted drug delivery via the transferrin receptor- (2002) Pharmacol. Rev., 54, pp. 561-587
Qiao, R., Yang, C., Gao, M., Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications (2009) J. Mater. Chem
Rajabi, M., Signorelli, P., Gorincioi, E., Ghidoni, R., Santaniello, E., Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study (2010) DNA Cell Biol., 29, pp. 687-691
Rajabi, M., Mehrzad, J., Gorincioi, E., Santaniello, E., Antiproliferative activity of N(6)-isopentenyladenosine on HCT-15 colon carcinoma cell line (2011) Nucleic Acid Ther., 21, pp. 355-358
Rajabi, M., Gorincioi, E., Santaniello, E., Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line (2012) Nucleosides Nucleotides Nucleic Acids, 31, pp. 474-481
Rao, C.N.R., Biswas, K., Characterization of nanomaterials by physical methods (2009) Annu. Rev. Anal. Chem. (Palo Alto Calif.), 2, pp. 435-462
Raz, A., Meromsky, L., Lotan, R., Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells (1986) Cancer Res., 46, pp. 3667-3672
Rubinstein, D.B., Stortchevoi, A., Boosalis, M., Ashfaq, R., Ghebrehiwet, B., Peerschke, E.I.B., Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells (2004) Int. J. Cancer, 110, pp. 741-750
Sahoo, S.K., Labhasetwar, V., Nanotech approaches to drug delivery and imaging (2003) Drug Discov. Today, 8, pp. 1112-1120
Santra, S., Kaittanis, C., Grimm, J., Perez, J.M., Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging (2009) Small, 5, pp. 1862-1868
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system (2005) Nature, 436, pp. 568-572
Shakesheff, K., Evora, C., Soriano, I., Langer, R., The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS) (1997) J. Colloid Interface Sci., 185, pp. 538-547
Sharpe, M., Easthope, S.E., Keating, G.M., Lamb, H.M., Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma (2002) Drugs, 62, pp. 2089-2126
Shen, Y., Tang, H., Radosz, M., Van Kirk, E., Murdoch, W.J., PH-responsive nanoparticles for cancer drug delivery (2008) Methods Mol. Biol., 437, pp. 183-216
Shin, J., Shum, P., Grey, J., Fujiwara, S.I., Malhotra, G.S., González-Bonet, A., Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics (2012) Mol. Pharm., 9, pp. 3266-3276
Shu, Y., Pi, F., Sharma, A., Rajabi, M., Haque, F., Shu, D., Stable RNA nanoparticles as potential new generation drugs for cancer therapy (2014) Adv. Drug Deliv. Rev., 66, pp. 74-89
Sinha, R., Kim, G.J., Nie, S., Shin, D.M., Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery (2006) Mol. Cancer Ther., 5, pp. 1909-1917
Smart, J.D., Lectin-mediated drug delivery in the oral cavity (2004) Adv. Drug Deliv. Rev
Sohma, Y., Kent, S.B.H., Biomimetic synthesis of lispro insulin via a chemically synthesized "mini-proinsulin" prepared by oxime-forming ligation (2009) J. Am. Chem. Soc., 131, pp. 16313-16318
Song, G., Petschauer, J.S., Madden, A.J., Zamboni, W.C., Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases (2014) Curr. Rheumatol. Rev., 10, pp. 22-34
Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., Biodegradable polymeric nanoparticles as drug delivery devices (2001) J. Control. Release, 70, pp. 1-20. , http://dx.doi.org/10.1016/S0168-3659(00)00339-4
Srinivasan, M., Rajabi, M., Mousa, S.A., Multifunctional nanomaterials and their applications in drug delivery and cancer therapy (2015) Nanomaterials, 5 (4), pp. 1690-1703
Straubinger, R.M., Lopez, N.G., Debs, R.J., Hong, K., Papahadjopoulos, D., Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes (1988) Cancer Res., 48, pp. 5237-5245
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome (2008) Int. J. Pharm., 346, pp. 143-150
Taheri, A., Dinarvand, R., Nouri, F.S., Khorramizadeh, M.R., Borougeni, A.T., Mansoori, P., Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy (2011) Int. J. Nanomed., 6, pp. 1863-1874
Tian, H., Tang, Z., Zhuang, X., Chen, X., Jing, X., Biodegradable synthetic polymers: preparation, functionalization and biomedical application (2012) Prog. Polym. Sci., 37, pp. 237-280
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., Boiocchi, M., Overexpression of folate binding protein in ovarian cancers (1997) Int. J. Cancer, 74, pp. 193-198. , http://dx.doi.org/10.1002/(SICI)1097-0215(19970422)74:2193:AID-IJC103.0.CO
2-F
Tong, R., Cheng, J., Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles (2009) J. Am. Chem. Soc., 131, pp. 4744-4754
Torchilin, V.P., Micellar nanocarriers: pharmaceutical perspectives (2007) Pharm. Res
Treat, J., Greenspan, A., Forst, D., Sanchez, J.A., Ferrans, V.J., Potkul, L.A., Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study (1990) J. Natl. Cancer Inst., 82, pp. 1706-1710
Treuel, L., Jiang, X., Nienhaus, G.U., New views on cellular uptake and trafficking of manufactured nanoparticles (2013) J. R. Soc. Interface., 10
Tuerk, C., Gold, L., Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase (1990) Science, 249, pp. 505-510
Uchida, M., Flenniken, M.L., Allen, M., Willits, D.A., Crowley, B.E., Brumfield, S., Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles (2006) J. Am. Chem. Soc., 128, pp. 16626-16633
Von Maltzahn, G., Ren, Y., Park, J.-H., Min, D.-H., Kotamraju, V.R., Jayakumar, J., In vivo tumor cell targeting with "click" nanoparticles (2008) Bioconjug. Chem., 19, pp. 1570-1578
Walling, M.A., Novak, J.A., Shepard, J.R.E., Quantum dots for live cell and in vivo imaging (2009) Int. J. Mol. Sci
Wang, B., Xu, C., Xie, J., Yang, Z., Sun, S., PH controlled release of chromone from chromone-Fe3O4 nanoparticles (2008) J. Am. Chem. Soc., 130, pp. 14436-14437
Wang, J., Byrne, J.D., Napier, M.E., DeSimone, J.M., More effective nanomedicines through particle design (2011) Small, 7, pp. 1919-1931
Wang, T., D'Souza, G.G.M., Bedi, D., Fagbohun, O.A., Potturi, L.P., Papahadjopoulos-Sternberg, B., Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein (2010) Nanomedicine (Lond.), 5, pp. 563-574
Wang, T., Petrenko, V.A., Torchilin, V.P., Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity (2010) Mol. Pharm., 7, pp. 1007-1014
Wang, X., Guo, Z., Targeting and delivery of platinum-based anticancer drugs (2013) Chem. Soc. Rev
Wang, Y.X., Hussain, S.M., Krestin, G.P., Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging (2001) Eur. Radiol., 11, pp. 2319-2331
Weinstein, J.S., Varallyay, C.G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W.D., Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review (2010) J. Cereb. Blood Flow Metab., 30, pp. 15-35
Wilson, D.S., Szostak, J.W., In vitro selection of functional nucleic acids (1999) Annu. Rev. Biochem., 68, pp. 611-647
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human (2004) Int. J. Pharm., 285, pp. 135-146
Wykosky, J., Debinski, W., The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting (2008) Mol. Cancer Res., 6, pp. 1795-1806
Xing, Y., Rao, J., Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging (2008) Cancer Biomark., 4, pp. 307-319
Xu, Z., Gu, W., Chen, L., Gao, Y., Zhang, Z., Li, Y., A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection (2008) Biomacromolecules, 9, pp. 3119-3126
Yamazaki, N., Kojima, S., Bovin, N.V., André, S., Gabius, S., Gabius, H.J., Endogenous lectins as targets for drug delivery (2000) Adv. Drug Deliv. Rev, , http://dx.doi.org/10.1016/S0169-409X(00)00071-5
Yang, W., Cheng, Y., Xu, T., Wang, X., Wen, L.P., Targeting cancer cells with biotin-dendrimer conjugates (2009) Eur. J. Med. Chem., 44, pp. 862-868
Yao, X.L., Yoshioka, Y., Ruan, G.X., Chen, Y.Z., Mizuguchi, H., Mukai, Y., Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy (2012) Biomacromolecules, 13, pp. 2402-2409
Yeung, T., Gilbert, G.E., Shi, J., Silvius, J., Kapus, A., Grinstein, S., Membrane phosphatidylserine regulates surface charge and protein localization (2008) Science, 319, pp. 210-213
Yhee, J.Y., Lee, S.J., Lee, S., Song, S., Min, H.S., Kang, S.W., Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice (2013) Bioconjug. Chem., 24, pp. 1850-1860
Yong, K.T., Qian, J., Roy, I., Lee, H.H., Bergey, E.J., Tramposch, K.M., Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells (2007) Nano Lett., 7, pp. 761-765
Yu, W.W., Chang, E., Drezek, R., Colvin, V.L., Water-soluble quantum dots for biomedical applications (2006) Biochem. Biophys. Res. Commun
Yu, X., Zhang, Y., Chen, C., Yao, Q., Li, M., Targeted drug delivery in pancreatic cancer (2010) Biochim. Biophys. Acta., 1805, pp. 97-104
Zha, L., Banik, B., Alexis, F., Stimulus responsive nanogels for drug delivery (2011) Soft Matter
Zhan, Q., Qian, J., Liang, H., Somesfalean, G., Wang, D., He, S., Using 915nm laser excited Tm3+/Er3+/Ho3+-doped NaYbF4 upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation (2011) ACS Nano, 5, pp. 3744-3757

Similar publications

Sorry the service is unavailable at the moment. Please try again later.